The Rockefeller University is a private graduate-only university in New York City. It focuses primarily on the biological and medical sciences and provides doctoral and postdoctoral education. It is classified among "R2: Doctoral Universities – High research activity".

During the past decade, The Rockefeller University conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 23 clinical trials were completed, i.e. on average, 59% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 11 clinical trials were completed. i.e. 73.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Rockefeller University" #1 sponsor was "Rockefeller University" with 75 trials, followed by "Pfizer" with 3 trials sponsored, "International AIDS Vaccine Initiative" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "Aaron Diamond AIDS Research Center" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Rockefeller University" #1 collaborator was "Weill Medical College of Cornell University" with 10 trials as a collaborator, "Rockefeller University" with 6 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials as a collaborator, "Brigham and Women's Hospital" with 2 trials as a collaborator and "Facet Biotech" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "The Rockefeller University" are "Psoriasis" (12 trials), "Obesity" (11 trials), "Healthy Volunteers" (8 trials), "HIV Infections" (6 trials) and "Human Immunodeficiency Virus" (6 trials). Many other conditions were trialed in "The Rockefeller University" in a lesser frequency.

Most popular intervention types in "The Rockefeller University" are "Drug" (49 trials), "Other" (18 trials), "Biological" (14 trials), "Dietary Supplement" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "3BNC117" (6 trials), "3BNC117-LS" (5 trials), "10-1074-LS" (4 trials) and "10-1074" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Rockefeller University" are 87 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "The Rockefeller University". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in The Rockefeller University, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in The Rockefeller University, 28 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 27 trials that are defined as “Not Applicable".